New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Trulieve Cannabis Corp.
TCNNF
Shape
US Flag

PNK

Unprofitable

EPS improving

Unprofitable

EPS improving

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 05 Nov 2024

2B

Drug Manufacturers - Specialty & Generic

Next Earning date - 05 Nov 2024

13.05USD
Shape-0.21 ( -1.58%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-72%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

10%

Quote Panel

Shape
Updated October 28, 2024
1W -1.88 % 1M 6.97 % 3M 29.72 % 1Y 227.07 %

Key Metrics

Shape
  • Market Cap

    2.44B


  • Shares Outstanding

    187.32M


  • Share in Float

    177.89M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    13.05


  • Average Volume

    323632


  • Beta

    1.432


  • Range

    3.79-14.5


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.trulieve.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.14x

P/S Ratio

1.84x

P/B Ratio

0.4

Debt/Equity

-9.0%

Net Margin

$-0.5

EPS

How TCNNF compares to sector?

P/E Ratio

Relative Strength

Shape

TCNNF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape308%

2025-Revenue

$0.25

Shape-244%

2025-EPS

$523M

Shape450%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wedbush

initialise

Previous: Not converted

2022-12-02

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-88%

0.02
vs 0.17

Q4.22

arrow
arrow

N/A

-0.41
vs -1.76

Q1.23

arrow
arrow

N/A

-0.34
vs -0.17

Q2.23

arrow
arrow

N/A

-0.51
vs -0.12

Q3.23

arrow
arrow

N/A

-0.14
vs 0.02

Q4.23

arrow
arrow

N/A

-0.18
vs -0.41

Q1.24

arrow
arrow

N/A

-0.12
vs -0.34

Q2.24

arrow
arrow

N/A

-0.06
vs -0.51

Q3.24

arrow
arrow

N/A

-0.10
vs -0.14

Q4.24

arrow
arrow

N/A

-0.09
vs -0.18

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+34%

300.8M  vs 224.1M

Q4.22

arrow
arrow

-1%

302.2M  vs 305.3M

Q1.23

arrow
arrow

-9%

289.1M  vs 318.3M

Q2.23

arrow
arrow

-12%

281.8M  vs 320.3M

Q3.23

arrow
arrow

-9%

275.2M  vs 300.8M

Q4.23

arrow
arrow

-2%

294.9M  vs 302.2M

Q1.24

arrow
arrow

+2%

296.3M  vs 289.1M

Q2.24

arrow
arrow

+8%

303.4M  vs 281.8M

Q3.24

arrow
arrow

+5%

289.8M  vs 275.2M

Q4.24

arrow
arrow

+2%

299.9M  vs 294.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-4%

-0.04
vs -0.01

Q4.22

arrow
arrow

-4%

-0.04
vs -0.04

Q1.23

arrow
arrow

-4%

-0.04
vs -0.04

Q2.23

arrow
arrow

-28%

-0.28
vs -0.04

Q3.23

arrow
arrow

-2%

-0.02
vs -0.28

Q4.23

arrow
arrow

-2%

-0.02
vs -0.02

Q1.24

arrow
arrow

-2%

-0.02
vs -0.02

Q2.24

arrow
arrow

-1%

-0.01
vs -0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

10

10
vs 13

-23%

Q4.22

arrow
arrow

11

11
vs 10

10%

Q1.23

arrow
arrow

10

10
vs 11

-9%

Q2.23

arrow
arrow

8

8
vs 10

-20%

Q3.23

arrow
arrow

7

7
vs 8

-12%

Q4.23

arrow
arrow

5

5
vs 7

-29%

Q1.24

arrow
arrow

4

4
vs 5

-20%

Q2.24

arrow
arrow

6

6
vs 4

50%

Earnings Growth

Latest News